恒瑞医药(01276.HK)11月11日耗资915.26万元回购15万股A股

Group 1 - The company, Heng Rui Pharmaceutical (01276.HK), announced a share buyback plan on November 11, 2025, involving an expenditure of RMB 9.1526 million to repurchase 150,000 A shares [1] - The buyback price per share is set between RMB 61.01 and RMB 61.07 [1]